Naim Ata

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 196 citations · Full text

The outcome of COVID‐19 in patients with hematological malignancy

Tuğçe Nur Yiğenoğlu, Naim Ata, Fevzi Altuntaş et al. · Journal of Medical Virology · 2020 · 129 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Intensive Care Unit +15

Increased Levels of 25 Hydroxyvitamin D and 1,25-Dihydroxyvitamin D After Rosuvastatin Treatment: A Novel Pleiotropic Effect of Statins?

Bünyamin Yavuz, Derun Taner Ertuğrul, Hicran Cil et al. · Cardiovascular Drugs and Therapy · 2009 · 119 citations

Cardiovascular Disease, Hydroxyvitamin D, Medicine +7

The role of Frailty on Adverse Outcomes Among Older Patients with COVID-19

Harun Kundi, Elif Hande Özcan Çetin, Uğur Canpolat et al. · Journal of Infection · 2020 · 108 citations · Full text

Aging, Geriatrics, Medicine +9

STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D

Derun Taner Ertuğrul, Bünyamin Yavuz, Hicran Cil et al. · Cardiovascular Therapeutics · 2010 · 81 citations

Nutrition, Metabolic Syndrome, Fluvastatin Treatment +14